Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update

T. Moseng, TPM. Vliet Vlieland, S. Battista, D. Beckwée, V. Boyadzhieva, PG. Conaghan, D. Costa, M. Doherty, AG. Finney, T. Georgiev, M. Gobbo, N. Kennedy, I. Kjeken, FPB. Kroon, LS. Lohmander, H. Lund, CD. Mallen, K. Pavelka, IA. Pitsillidou,...

. 2024 ; 83 (6) : 730-740. [pub] 20240515

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, směrnice pro lékařskou praxi

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013932

INTRODUCTION: Hip and knee osteoarthritis (OA) are increasingly common with a significant impact on individuals and society. Non-pharmacological treatments are considered essential to reduce pain and improve function and quality of life. EULAR recommendations for the non-pharmacological core management of hip and knee OA were published in 2013. Given the large number of subsequent studies, an update is needed. METHODS: The Standardised Operating Procedures for EULAR recommendations were followed. A multidisciplinary Task Force with 25 members representing 14 European countries was established. The Task Force agreed on an updated search strategy of 11 research questions. The systematic literature review encompassed dates from 1 January 2012 to 27 May 2022. Retrieved evidence was discussed, updated recommendations were formulated, and research and educational agendas were developed. RESULTS: The revised recommendations include two overarching principles and eight evidence-based recommendations including (1) an individualised, multicomponent management plan; (2) information, education and self-management; (3) exercise with adequate tailoring of dosage and progression; (4) mode of exercise delivery; (5) maintenance of healthy weight and weight loss; (6) footwear, walking aids and assistive devices; (7) work-related advice and (8) behaviour change techniques to improve lifestyle. The mean level of agreement on the recommendations ranged between 9.2 and 9.8 (0-10 scale, 10=total agreement). The research agenda highlighted areas related to these interventions including adherence, uptake and impact on work. CONCLUSIONS: The 2023 updated recommendations were formulated based on research evidence and expert opinion to guide the optimal management of hip and knee OA.

Center for treatment of Rheumatic and Musculoskeletal Diseases Diakonhjemmet Hospital Oslo Norway

Centre for Evidence Based Practice Western Norway University of Applied Sciences Bergen Norway

Clinic of Rheumatology University Hospital St Marina 1st Department of Internal Medicine Medical University Varna Varna Bulgaria

Comprehensive Health Research Center Universidade Nova de Lisboa Lisboa Portugal

Department of Academic Rheumatology University of Nottingham Nottingham UK

Department of Clinical Sciences Lund Orthopaedics Lund University Lund Sweden

Department of Nutritional Sciences University of Surrey Faculty of Health and Medical Sciences Guildford UK

Department of Orthopaedics Rehabilitation and Physical Therapy Leiden University Medical Center Leiden Netherlands

Department of Rheumatology Leiden University Medical Center Leiden The Netherlands

Department of Rheumatology Zuyderland Medical Centre Heerlen Heerlen The Netherlands

EULAR Patient Research Partner Cyprus League Against Rheumatism Nicosia Cyprus

EULAR Patient Research Partner Deutsche Rheuma Liga Bonn Germany

Institute of Rheumatology Department of Rheumatology Charles University 1st Faculty of Medicine Praha Czech Republic

Keele University School of Medicine Keele UK

Leeds Institute of Rheumatic and Musculoskeletal Medicine University of Leeds and NIHR Leeds Biomechanical Reserch Centre Leeds UK

Orthopaedic Ward Casa di Cura Santa Maria Maddalena Novara Italy

Positivamente Centro de Psicología Madrid Spain

Rehabilitation Research Department Vrije Universiteit Brussel Brussel Belgium

Research and Innovation Sint Maartenskliniek Nijmegen The Netherlands

Research Institute for Primary Care and Health Sciences Keele University School of Medicine Keele UK

School of Allied Health Faculty of Education and Health Sciences and Health Research Institute University of Limerick Limerick Ireland

School of Nursing and Midwifery Keele University Keele UK

UMHAT St Iv Rilski Clinic of Rheumatology Medical University Sofia Sofia Bulgaria

University of Genoa Department of Neuroscience Ophthalmological Rehabilitation Genetics and Mother and Child Health Genova Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013932
003      
CZ-PrNML
005      
20240905133316.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ard-2023-225041 $2 doi
035    __
$a (PubMed)38212040
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Moseng, Tuva $u Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway tuva.moseng@diakonsyk.no $1 https://orcid.org/000000030920888X
245    10
$a EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update / $c T. Moseng, TPM. Vliet Vlieland, S. Battista, D. Beckwée, V. Boyadzhieva, PG. Conaghan, D. Costa, M. Doherty, AG. Finney, T. Georgiev, M. Gobbo, N. Kennedy, I. Kjeken, FPB. Kroon, LS. Lohmander, H. Lund, CD. Mallen, K. Pavelka, IA. Pitsillidou, MP. Rayman, AT. Tveter, JE. Vriezekolk, D. Wiek, G. Zanoli, N. Østerås
520    9_
$a INTRODUCTION: Hip and knee osteoarthritis (OA) are increasingly common with a significant impact on individuals and society. Non-pharmacological treatments are considered essential to reduce pain and improve function and quality of life. EULAR recommendations for the non-pharmacological core management of hip and knee OA were published in 2013. Given the large number of subsequent studies, an update is needed. METHODS: The Standardised Operating Procedures for EULAR recommendations were followed. A multidisciplinary Task Force with 25 members representing 14 European countries was established. The Task Force agreed on an updated search strategy of 11 research questions. The systematic literature review encompassed dates from 1 January 2012 to 27 May 2022. Retrieved evidence was discussed, updated recommendations were formulated, and research and educational agendas were developed. RESULTS: The revised recommendations include two overarching principles and eight evidence-based recommendations including (1) an individualised, multicomponent management plan; (2) information, education and self-management; (3) exercise with adequate tailoring of dosage and progression; (4) mode of exercise delivery; (5) maintenance of healthy weight and weight loss; (6) footwear, walking aids and assistive devices; (7) work-related advice and (8) behaviour change techniques to improve lifestyle. The mean level of agreement on the recommendations ranged between 9.2 and 9.8 (0-10 scale, 10=total agreement). The research agenda highlighted areas related to these interventions including adherence, uptake and impact on work. CONCLUSIONS: The 2023 updated recommendations were formulated based on research evidence and expert opinion to guide the optimal management of hip and knee OA.
650    _2
$a lidé $7 D006801
650    12
$a artróza kolenních kloubů $x terapie $x rehabilitace $7 D020370
650    12
$a artróza kyčelních kloubů $x terapie $x rehabilitace $7 D015207
650    12
$a terapie cvičením $x metody $7 D005081
650    _2
$a vzdělávání pacientů jako téma $x metody $7 D010353
650    _2
$a self-management $x metody $7 D000073278
650    _2
$a pomůcky pro sebeobsluhu $7 D012656
650    _2
$a medicína založená na důkazech $7 D019317
650    _2
$a hmotnostní úbytek $7 D015431
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
700    1_
$a Vliet Vlieland, Theodora P M $u Department of Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center (LUMC), Leiden, Netherlands $1 https://orcid.org/0000000163223859
700    1_
$a Battista, Simone $u University of Genoa Department of Neuroscience Ophthalmological Rehabilitation Genetics and Mother and Child Health, Genova, Italy
700    1_
$a Beckwée, David $u Rehabilitation Research Department, Vrije Universiteit Brussel, Brussel, Belgium
700    1_
$a Boyadzhieva, Vladimira $u UMHAT "St. Iv. Rilski" Clinic of Rheumatology, Medical University Sofia, Sofia, Bulgaria
700    1_
$a Conaghan, Philip G $u Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomechanical Reserch Centre, Leeds, UK $1 https://orcid.org/0000000234785665
700    1_
$a Costa, Daniela $u Comprehensive Health Research Center (CHRC), Universidade Nova de Lisboa, Lisboa, Portugal
700    1_
$a Doherty, Michael $u Department of Academic Rheumatology, University of Nottingham, Nottingham, UK
700    1_
$a Finney, Andrew G $u Research Institute for Primary Care and Health Sciences, Keele University School of Medicine, Keele, UK $u School of Nursing and Midwifery, Keele University, Keele, UK
700    1_
$a Georgiev, Tsvetoslav $u Clinic of Rheumatology, University Hospital St. Marina, First Department of Internal Medicine, Medical University Varna, Varna, Bulgaria
700    1_
$a Gobbo, Milena $u Positivamente Centro de Psicología, Madrid, Spain
700    1_
$a Kennedy, Norelee $u School of Allied Health, Faculty of Education and Health Sciences and Health Research Institute, University of Limerick, Limerick, Ireland
700    1_
$a Kjeken, Ingvild $u Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway
700    1_
$a Kroon, Féline P B $u Department of Rheumatology, Leiden University Medical Center (LUMC), Leiden, The Netherlands $u Department of Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands $1 https://orcid.org/0000000289400582
700    1_
$a Lohmander, L Stefan $u Department of Clinical Sciences Lund, Orthopaedics, Lund University, Lund, Sweden $1 https://orcid.org/0000000254249448
700    1_
$a Lund, Hans $u Centre for Evidence-Based Practice, Western Norway University of Applied Sciences, Bergen, Norway
700    1_
$a Mallen, Christian D $u Keele University School of Medicine, Keele, UK
700    1_
$a Pavelka, Karel $u Institute of Rheumatology, Department of Rheumatology, Charles University First Faculty of Medicine, Praha, Czech Republic
700    1_
$a Pitsillidou, Irene A $u EULAR Patient Research Partner, Cyprus League Against Rheumatism, Nicosia, Cyprus
700    1_
$a Rayman, Margaret P $u Department of Nutritional Sciences, University of Surrey Faculty of Health and Medical Sciences, Guildford, UK
700    1_
$a Tveter, Anne Therese $u Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway
700    1_
$a Vriezekolk, Johanna E $u Research & Innovation, Sint Maartenskliniek, Nijmegen, The Netherlands $1 https://orcid.org/0000000347838663
700    1_
$a Wiek, Dieter $u EULAR Patient Research Partner, Deutsche Rheuma-Liga, Bonn, Germany
700    1_
$a Zanoli, Gustavo $u Orthopaedic Ward, Casa di Cura Santa Maria Maddalena, Novara, Italy
700    1_
$a Østerås, Nina $u Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway $1 https://orcid.org/000000018602342X
773    0_
$w MED00000444 $t Annals of the rheumatic diseases $x 1468-2060 $g Roč. 83, č. 6 (2024), s. 730-740
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38212040 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133310 $b ABA008
999    __
$a ok $b bmc $g 2143627 $s 1225798
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 83 $c 6 $d 730-740 $e 20240515 $i 1468-2060 $m Annals of the rheumatic diseases $n Ann Rheum Dis $x MED00000444
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace